GurkamalChattaMD

PubMed

• Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
  Li, W., Wang, Y., Liu, X., Wu, S., Wang, M., Turowski, S., Spernyak, J., Tracz, A., Abdelaal, A., Sudarshan, K., Kasinski, A., Tang, D., Puzanov, I., Chatta, G.> ;International Journal of Molecular Sciences. 2024 Feb 9
• Psychological Distress, Emergency Room Utilization, and Mortality Risk Among US Adults With History of Prostate Cancer.
  Changchuan Jiang, Jiazhang Xing, Alexandra Sanders, Kaitlin Chidester, Molin Shi, Stuthi Perimbeti, Lei Deng, Gurkamal S Chatta, Dharmesh Gopalakrishnan> ;JCO Oncology Practice. 2024 Apr 1
• 1 citations
  Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.
  Ulka N Vaishampayan, Lance Heilbrun, Nitin Vaishampayan, Dongping Shi, Daryn Smith, Kelly Green, Khurshid Guru, Qiang Li, Michael Kuettel, Gurkamal Chatta, Jordan Maie...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 1
• 14 citations
  Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib.
  Andrea Loehr, Arif Hussain, Akash Patnaik, Alan H Bryce, Daniel Castellano, Albert Font, Jeremy Shapiro, Jingsong Zhang, Brieuc Sautois, Nicholas J Vogelzang, Gurkamal...> ;European Urology. 2023 Mar 1
• 8 citations
  Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness.
  Xiaozhuo Liu, Wen Jess Li, Igor Puzanov, David W Goodrich, Gurkamal Chatta, Dean G Tang> ;Essays in Biochemistry. 2022 Sep 16
• 2 citations
  A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
  Dongbo Xu, Qiang Cao, Li Wang, Jianmin Wang, Bo Xu, Kristopher Attwood, Lei Wei, Yue Wu, Gary J Smith, Eriko Katsuta, Kazuaki Takabe, Gurkamal Chatta, David W Goodrich...> ;Molecular Cancer Therapeutics. 2022 May 4
• 4 citations
  Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the Int...
  Dharmesh Gopalakrishnan, Ahmed S Elsayed, Ahmed A Hussein, Zhe Jing, Qiang Li, Andrew A Wagner, Ahmed Aboumohamed, Morgan Roupret, Derya Balbay, Carl Wijburg, Michael ...> ;International Journal of Urology. 2022 Mar 1
• 1 citations
  Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.
  James Ellegate Jr, Michalis Mastri, Emily Isenhart, John J Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt, Kevin H Eng> ;Cancers. 2022 Jan 30
• 37 citations
  Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance.
  Anmbreen Jamroze, Gurkamal Chatta, Dean G. Tang> ;Cancer Letters. 2021 Jun 9
• 9 citations
  NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues.
  Omar M. Ibrahim, Per H. Basse, Weijian Jiang, Khurshid A. Guru, Gurkamal Chatta, Pawel Kalinski> ;Cancers. 2021 Mar 16
• 66 citations
  T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
  Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood, Sebastiano Battaglia, Saby George, Gurkamal Chatta, Igor Puzanov, Carl...> ;Nature Communications. 2021 Mar 3
• 11 citations
  Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the ur...
  David I. Quinn, Denice D. Tsao-Wei, Przemyslaw Twardowski, Ana Aparicio, Paul Frankel, Gurkamal Chatta, John Wright, Susan Groshen, Stella Khoo, Heinz-Josef Lenz, Prim...> ;Investigational New Drugs. 2021 Jan 6
• 6 citations
  Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment.
  Michalis Mastri, Swathi Ramakrishnan, Shruti D Shah, Ellen Karasik, Bryan M Gillard, Michael T Moser, Bailey K Farmer, Gissou Azabdaftari, Gurkamal S Chatta, Anna Wolo...> ;American Journal of Clinical and Experimental Urology. 2021 Jan 1
• 35 citations
  High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy.
  Yuanquan Yang, Kristopher Attwood, Wiam Bshara, James L. Mohler, Khurshid A. Guru, Bo Xu, Pawel Kalinski, Gurkamal Chatta> ;The Prostate. 2021 Jan 1
• 5 citations
  Role of tumor microenvironment in the efficacy of BCG therapy.
  Omar M. Ibrahim, Ravindra K. Pandey, Gurkamal Chatta, Pawel Kalinski> ;Trends in Research. 2020 Aug 17
• 16 citations
  Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.
  Melissa Dolan, Michalis Mastri, Amanda Tracz, James G. Christensen, Gurkamal Chatta, John M.L. Ebos> ;Plos One. 2019 Aug 1
• 13 citations
  Oncologist uptake of comprehensive genomic profile guided targeted therapy.
  , , , , , , , , , , , , , , , , , , , , > ;Oncotarget. 2019 Jul 23
• 23 citations
  Identification of targets for prostate cancer immunotherapy.
  Antonios Papanicolau-Sengos, Yuanquan Yang, Sarabjot Pabla, Felicia L. Lenzo, Shumei Kato, Razelle Kurzrock, Paul DePietro, Mary Nesline, Jeffrey M. Conroy, Sean T. Gl...> ;The Prostate. 2019 Apr 1
• 54 citations
  Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
  Swathi Ramakrishnan, Victoria Granger, Monika Rak, Qiang Hu, Kristopher Attwood, Lanni Aquila, Nithya Krishnan, Rafal Osiecki, Gissou Azabdaftari, Khurshid A. Guru, Gu...> ;Cell Death and Differentiation. 2019 Jan 28
• 11 citations
  Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
  Grace K. Dy, Mary Nesline, Antonios Papanicolau-Sengos, Paul DePietro, Charles LeVea, Amy P. Early, Hongbin Chen, Anne Grand'Maison, Patrick McKay Boland, Marc S. Erns...> ;BMC Medical Informatics and Decision Making. 2019 Jan 18
• 32 citations
  Serum Metabolic Profiling Identified a Distinct Metabolic Signature in Bladder Cancer Smokers: A Key Metabolic Enzyme Associated with Patient Survival.
  Chandra Sekhar Amara, Chandrashekar R. Ambati, Venkatrao Vantaku, Danthasinghe Waduge Badrajee Piyarathna, Sri Ramya Donepudi, Shiva Shankar Ravi, James M. Arnold, Vas...> ;Cancer Epidemiology, Biomarkers & Prevention. 2019 Jan 14
• 87 citations
  Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.
  Qiuhui Li, Qu Deng, Hsueh Ping Chao, Xin Liu, Yue Lu, Kevin Lin, Bigang Liu, Gregory W. Tang, Dingxiao Zhang, Amanda Tracz, Collene R. Jeter, Kiera Rycaj, Tammy Calhou...> ;Nature Communications. 2018 Sep 6
• 21 citations
  Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
  Swathi Ramakrishnan, Qiang Hu, Nithya Krishnan, Dan Wang, Evelyn Smit, Victoria Granger, Monika Rak, Kristopher Attwood, Candace S. Johnson, Carl Morrison, Roberto Pil...> ;Cell Death & Disease. 2017 Dec 14
• 14 citations
  Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice
  Richard W. Joseph, Gurkamal Chatta, Ulka N. Vaishampayan> ;Urologic Oncology. 2017 Apr 1
• 8 citations
  Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (On...
  Susanne M. Arnold, Kari Chansky, Markos Leggas, Michael A. Thompson, John L. Villano, John T. Hamm, Rachel E. Sanborn, Glen J. Weiss, Gurkamal Chatta, Maria Q. Baggstrom> ;Investigational New Drugs. 2017 Feb 16
• Join now to see all